Circular RNA circ_0020123 Promotes Non-Small Cell Lung Cancer Progression Through miR-384/TRIM44 Axis

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. doi:10.3322/caac.2013822237781
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–271. doi:10.3322/caac.2123524890451
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Hou MM, Chang JW, Shen YC, Cheng HY, Hsu T. RAB38 is a potential prognostic factor for tumor recurrence in non-small cell lung cancer. Oncol Lett. 2019;18:2598–2604.31452745
   PubMed Web of Science ®Google Scholar
• Rybak-Wolf A, Stottmeister C, Glazar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870–885. doi:10.1016/j.molcel.2015.03.02725921068
   PubMed Web of Science ®Google Scholar
• Bolha L, Ravnik-Glavac M. Circular RNAs: biogenesis, function, and a role as possible cancer. Biomarkers. 2017;2017:6218353.
   Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134. doi:10.1016/j.cell.2015.02.01425768908
   PubMed Web of Science ®Google Scholar
• Hao S, Lv J, Yang Q, et al. Identification of key genes and circular RNAs in human gastric cancer. Med Sci Monit. 2019;25:2488–2504. doi:10.12659/MSM.91538230948703
   PubMed Web of Science ®Google Scholar
• Zhang S-J, Chen X, Li C-P, et al. Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy. Invest Ophthalmol Vis Sci. 2017;58(14):6500–6509. doi:10.1167/iovs.17-2269829288268
   PubMed Web of Science ®Google Scholar
• Wang W, Wang Y, Piao H, et al. Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease. PeerJ. 2019;7:e6831.31119072
   PubMed Web of Science ®Google Scholar
• Wan J, Hao L, Zheng X, Li Z. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488–3p to regulate ADAM9 expression. Biochem Biophys Res Commun. 2019;515(2):303–309. doi:10.1016/j.bbrc.2019.05.15831153639
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Fan N, Zhang J, Cheng C, Zhang X, Feng J, Kong R. MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling. Biomed Pharmacother. 2017;95:1331–1337. doi:10.1016/j.biopha.2017.08.14328938524
   PubMed Web of Science ®Google Scholar
• Li J, Chen M, Yu B. miR-433 suppresses tumor progression via Smad2 in non-small cell lung cancer. Pathol Res Pract. 2019;215(10):152591. doi:10.1016/j.prp.2019.15259131445716
   PubMed Web of Science ®Google Scholar
• Iacona JR, Monteleone NJ. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC). cells. 2019;1–12.
   PubMedGoogle Scholar
• Guo Q, Zheng M. MiR-384 induces apoptosis and autophagy of non-small cell lung cancer cells through the negative regulation of Collagen alpha-1(X) chain gene. 2019;39.
   Google Scholar
• Wei CY, Wang L, Zhu MX, et al. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4. J Exp Clin Cancer Res. 2019;38:137. doi:10.1186/s13046-019-1138-730922374
   PubMed Web of Science ®Google Scholar
• Liu S, Meng F, Ding J, et al. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer. Biosci Rep. 2019;39.
   Web of Science ®Google Scholar
• Li L, Shao MY, Zou SC, Xiao ZF, Chen ZC. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neuro-Oncol. 2019;141:19–30.
   PubMed Web of Science ®Google Scholar
• Liu S, Yin H, Ji H, Zhu J, Ma R. Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer. Exp Ther Med. 2018;16:3034–3040.30214522
   PubMed Web of Science ®Google Scholar
• Xiong D, Jin C, Ye X, et al. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway. Cancer Sci. 2018;109:3080–3092.30098109
   PubMed Web of Science ®Google Scholar
• Luo Q, Lin H, Ye X, Huang J, Lu S, Xu L. Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-kappaB signaling pathway. Int J Clin Oncol. 2015;20:508–517. doi:10.1007/s10147-014-0752-925345539
   PubMed Web of Science ®Google Scholar
• Liu YT, Han XH, Xing PY, et al. Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer. J Thorac Dis. 2019;11:1779–1787. doi:10.21037/jtd.2019.05.2231285870
   PubMed Web of Science ®Google Scholar
• Chen T, Luo J. Comprehensive analysis of circular RNA profiling in AZD9291-resistant non-small cell lung cancer cell lines. Thorac Cancer. 2019;10:930–941.30883029
   PubMed Web of Science ®Google Scholar
• Cui J, Li W, Liu G, et al. A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f. Artif Cells Nanomed Biotechnol. 2019;47:810–821. doi:10.1080/21691401.2019.157584730873868
   PubMed Web of Science ®Google Scholar
• Wang L, Tong X, Zhou Z, et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer. Mol Cancer. 2018;17:140.30261900
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zheng X, Xu B, et al. Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183/PDPK1 signaling pathway. Biochem Biophys Res Commun. 2019;508:527–535. doi:10.1016/j.bbrc.2018.11.15730509491
   PubMed Web of Science ®Google Scholar
• Qu D, Yan B, Xin R, Ma T. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res. 2018;8:1387–1402.30210911
   PubMed Web of Science ®Google Scholar
• Piwecka M, Glazar P. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017;357.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang H, Li Y. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP. Artif Cells Nanomed Biotechnol. 2019;47(1):1458–1465. doi:10.1080/21691401.2019.160109931007083
   PubMed Web of Science ®Google Scholar
• Hong Z, Fu W, Wang Q, Zeng Y, Qi L. MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7. Biomed Pharmacother. 2019;114:108822. doi:10.1016/j.biopha.2019.10882230951946
   PubMed Web of Science ®Google Scholar
• Wang F. miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells. J Int Med Res. 2019;47(2):926–935. doi:10.1177/030006051881717130614349
   PubMed Web of Science ®Google Scholar
• Zhou W, Wang H, Yang J, et al. Down-regulated circPAPPA suppresses the proliferation and invasion of trophoblast cells via the miR-384/STAT3 pathway. Biosci Rep. 2019;39(9). doi:10.1042/BSR20191965
   Web of Science ®Google Scholar
• Wang L, Su K, Wu H, Li J, Song D. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis. Life Sci. 2019;232:116597. doi:10.1016/j.lfs.2019.11659731238052
   PubMed Web of Science ®Google Scholar
• Qian W, Ren Z, Lu X. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384. Biochem Biophys Res Commun. 2019;509(1):56–63. doi:10.1016/j.bbrc.2018.12.01130581000
   PubMed Web of Science ®Google Scholar
• Zhu L, Yang N, Li C, Liu G, Pan W, Li X. Long noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR-384. J Cell Biochem. 2018.
   Web of Science ®Google Scholar
• Doench JG. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18(5):504–511. doi:10.1101/gad.118440415014042
   PubMed Web of Science ®Google Scholar